Crescent Capital BDC (CCAP) to Release Earnings on Wednesday

Crescent Capital BDC (NASDAQ:CCAP) is projected to issue its Q4 2025 results after the market closes on Wednesday, February 18th. Analysts expect the company to announce earnings of $0.44 per share and revenue of $39.83 million for the quarter. Parties may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Thursday, February 26, 2026 at 12:00 PM ET.

Crescent Capital BDC (NASDAQ:CCAP) last issued its earnings results on Wednesday, November 12th. The company reported $0.46 EPS for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.01). The firm had revenue of $41.35 million during the quarter, compared to analysts’ expectations of $42.35 million. Crescent Capital BDC had a net margin of 20.84% and a return on equity of 9.76%.

Crescent Capital BDC Trading Down 0.7%

Shares of NASDAQ CCAP opened at $14.23 on Wednesday. The stock has a market cap of $526.37 million, a price-to-earnings ratio of 14.52 and a beta of 0.55. The business has a 50 day simple moving average of $14.53 and a 200 day simple moving average of $14.57. Crescent Capital BDC has a 52 week low of $13.03 and a 52 week high of $20.19. The company has a debt-to-equity ratio of 1.23, a quick ratio of 1.20 and a current ratio of 1.20.

Institutional Investors Weigh In On Crescent Capital BDC

Several hedge funds and other institutional investors have recently modified their holdings of CCAP. Royal Bank of Canada raised its stake in Crescent Capital BDC by 3.6% during the 1st quarter. Royal Bank of Canada now owns 61,707 shares of the company’s stock valued at $1,056,000 after purchasing an additional 2,128 shares during the last quarter. XTX Topco Ltd acquired a new stake in Crescent Capital BDC in the 2nd quarter worth $165,000. Quantbot Technologies LP bought a new position in shares of Crescent Capital BDC during the 2nd quarter worth about $219,000. Invesco Ltd. raised its position in shares of Crescent Capital BDC by 31.4% during the second quarter. Invesco Ltd. now owns 38,377 shares of the company’s stock valued at $541,000 after buying an additional 9,180 shares during the last quarter. Finally, Jump Financial LLC acquired a new position in shares of Crescent Capital BDC during the second quarter valued at about $286,000. Institutional investors and hedge funds own 49.46% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have commented on CCAP shares. Keefe, Bruyette & Woods decreased their target price on shares of Crescent Capital BDC from $17.00 to $15.50 and set an “outperform” rating for the company in a research report on Friday, November 14th. Zacks Research lowered shares of Crescent Capital BDC from a “hold” rating to a “strong sell” rating in a research note on Monday, January 12th. Oppenheimer decreased their price objective on shares of Crescent Capital BDC from $20.00 to $19.00 and set an “outperform” rating for the company in a report on Friday, November 14th. Wall Street Zen upgraded Crescent Capital BDC from a “sell” rating to a “hold” rating in a report on Saturday, January 10th. Finally, Wells Fargo & Company reduced their price target on Crescent Capital BDC from $15.00 to $14.00 and set an “equal weight” rating for the company in a research report on Friday, November 14th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $16.38.

About Crescent Capital BDC

Crescent Capital BDC, Inc is a closed-end, externally managed business development company that provides flexible financing solutions to middle market companies in the United States. Trading on the Nasdaq under the ticker CCAP, the firm offers investors exposure to a diversified portfolio of debt and equity instruments, targeting businesses with attractive risk-adjusted return profiles. Its primary objective is to generate current income through interest payments and potential capital appreciation via selective equity co-investments.

The company’s investment strategy emphasizes senior secured loans, unsecured second-lien loans, mezzanine debt, as well as preferred and common equity co-investments.